Evidence map›Paper›PMID 32056070›Full record

ArticleJournal of thrombosis and thrombolysis2020

Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report.

Guillaume Roberge, Tobias Tritschler, Caleb MacGillivray, Laurence Dufresne, Sudhir Kumar Nagpal, Dimitrios Scarvelis

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Autoimmune Heparin-Induced Thrombocytopenia.Journal of clinical medicine · 2023
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Guillaume RobergeDepartment of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada. guillaume.roberge.2@ulaval.ca.ORCID http://orcid.org/0000-0001-9294-0662
Tobias TritschlerDepartment of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Caleb MacGillivrayClinical Epidemiology Program, Thrombosis Research Group, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Laurence DufresneDivision of Vascular Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Sudhir Kumar NagpalDivision of Vascular Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Dimitrios ScarvelisDepartment of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
University of Ottawa · CAUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persisting heparin-induced thrombocytopenia (HIT) is characterized by ongoing thrombocytopenia more than 7 days after stopping heparin. It is part of cases referred to as autoimmune HIT (aHIT). In contrast to typical HIT cases, aHIT involves heparin-independent platelet activation mechanism highlighted by a strongly positive functional assay done without heparin. We report the first case of persisting HIT after an elective abdominal aortic aneurysm repair presenting with arterial and venous thrombosis, and describe the potential role of intravenous immunoglobulin in such patients.

Indexed as

AgedAnticoagulantsAortic Aneurysm, AbdominalHeparinHumansImmunoglobulins, IntravenousMaleThrombocytopeniaThrombosisAnticoagulantsHeparinImmunoglobulins, IntravenousCase reportHeparinImmunoglobulinThrombocytopeniaThrombosis

Identifiers

PMID32056070
OpenAlexW3006046343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.